# Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass

> **NCT02952963** · PHASE4 · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 8 (actual)

## Conditions studied

- Severe Obesity

## Interventions

- **DRUG:** Chenodeoxycholic Acid
- **DRUG:** Colesevelam

## Key facts

- **NCT ID:** NCT02952963
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-12
- **Final completion:** 2020-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952963, "Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02952963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*